These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2650931)

  • 1. An adrenal cyst associated with 19-nor-deoxycorticosterone excess and low renin hypertension.
    Griffing GT; Chobainian AV; Egdahl R; Ehlers ME; Melby JC
    Clin Exp Hypertens A; 1989; 11(2):317-21. PubMed ID: 2650931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of 19-nor-deoxycorticosterone to other mineralocorticoids in low-renin hypertension.
    Griffing GT; Dale SL; Holbrook MM; Melby JC
    Hypertension; 1983; 5(3):385-9. PubMed ID: 6341221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 19-nor-deoxycorticosterone excretion in primary aldosteronism and low renin hypertension.
    Griffing GT; Dale SL; Holbrook MM; Melby JC
    J Clin Endocrinol Metab; 1983 Feb; 56(2):218-21. PubMed ID: 6337172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inappropriate elevation of the aldosterone/plasma renin activity ratio in hypertensive patients with increases of 11-deoxycorticosterone and 18-hydroxy-11-deoxycorticosterone: a subtype of essential hypertension?
    Komiya I; Yamada T; Aizawa T; Takasu N; Niwa A; Maruyama Y; Ogawa A
    Cardiology; 1991; 78(2):99-110. PubMed ID: 2070375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 19-Nor-corticosteroids in health, in hypertensive states in humans including 17 alpha-hydroxylase deficiency and in the spontaneously hypertensive rat (SHR).
    Melby JC; Dale SL; Holbrook M; Wilson TE; Griffing GT; Arison BH
    Endocr Res; 1984-1985; 10(3-4):591-607. PubMed ID: 6336061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of 18-hydroxy-11-deoxycorticosterone and 16 alpha, 18-dihydroxy-11-deoxycorticosterone in hypertension.
    Melby JC; Dale SL
    Mayo Clin Proc; 1977 May; 52(5):317-22. PubMed ID: 870774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The regulation of urinary free 19-nor-deoxycorticosterone and its relation to systemic arterial blood pressure in normotensive and hypertensive subjects.
    Griffing GT; Dale SL; Holbrook MM; Melby JC
    J Clin Endocrinol Metab; 1983 Jan; 56(1):99-103. PubMed ID: 6292258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mineralocorticoid secretion in essential hypertension with normal and low plasma renin activity.
    Messerli FH; Kuchel O; Nowaczynski W; Seth K; Honda M; Kubo S; Boucher R; Tolis G; Genest J
    Circulation; 1976 Mar; 53(3):406-10. PubMed ID: 1248073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertension due to a deoxycorticosterone-secreting adrenal tumour diagnosed during pregnancy.
    Marques P; Tufton N; Bhattacharya S; Caulfield M; Akker SA
    Endocrinol Diabetes Metab Case Rep; 2019 May; 2019():. PubMed ID: 31051469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adrenocortical carcinoma producing 11-deoxycorticosterone: a rare cause of mineralocorticoid hypertension.
    Müssig K; Wehrmann M; Horger M; Maser-Gluth C; Häring HU; Overkamp D
    J Endocrinol Invest; 2005 Jan; 28(1):61-5. PubMed ID: 15816373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigating mineralocorticoid hypertension.
    Nussberger J
    J Hypertens Suppl; 2003 May; 21(2):S25-30. PubMed ID: 12929904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary free 19-nor-deoxycorticosterone and deoxycorticosterone in human hypertension.
    Gomez-Sanchez CE; Holland OB; Upcavage R
    J Clin Endocrinol Metab; 1985 Feb; 60(2):234-8. PubMed ID: 3880766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma and urinary 19-nor-deoxycorticosterone in 17 alpha-hydroxylase deficiency syndrome.
    Griffing GT; Wilson TE; Holbrook MM; Dale SL; Jackson TK; Ullrich I; Melby JC
    J Clin Endocrinol Metab; 1984 Nov; 59(5):1011-5. PubMed ID: 6332824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response of several adrenal steroids to ACTH stimulation in essential hypertension.
    Honda M; Nowaczynski W; Guthrie GP; Messerli FH; Tolis G; Kuchel O; Genest J
    J Clin Endocrinol Metab; 1977 Feb; 44(2):264-72. PubMed ID: 190252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mineralocorticoid hypertension in childhood.
    New MI; Levine LS
    Mayo Clin Proc; 1977 May; 52(5):323-8. PubMed ID: 323586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated urinary 19-Nor-deoxycorticosterone glucuronide in Cushing's syndrome.
    Ehlers ME; Griffing GT; Wilson TE; Melby JC
    J Clin Endocrinol Metab; 1987 May; 64(5):926-30. PubMed ID: 3558730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unconjugated and conjugated urinary 19-nor-deoxycorticosterone glucosiduronate. Elevated levels in essential hypertension.
    Griffing GT; Wilson TE; Melby JC
    Hypertension; 1985; 7(3 Pt 2):I12-7. PubMed ID: 3873413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adrenocortical factors in hypertension. I. Significance of 18-hydroxy-11-deoxycorticosterone.
    Ulick S
    Am J Cardiol; 1976 Nov; 38(6):814-24. PubMed ID: 187051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steroid characteristics of mineralocorticoid adrenocortical hypertension.
    Biglieri EG; Kater CE
    Clin Chem; 1991 Oct; 37(10 Pt 2):1843-8. PubMed ID: 1914200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low renin essential hypertension: failure to demonstrate excess 11-deoxycorticosterone production.
    Tan SY; Mulrow PJ
    J Clin Endocrinol Metab; 1979 Nov; 49(5):790-3. PubMed ID: 489719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.